These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28618255)

  • 1. Osteocyte Regulation of Receptor Activator of NF-κB Ligand/Osteoprotegerin in a Sheep Model of Osteoporosis.
    El Khassawna T; Merboth F; Malhan D; Böcker W; Daghma DES; Stoetzel S; Kern S; Hassan F; Rosenbaum D; Langenstein J; Bauer N; Schlagenhauf A; Rösen-Wolff A; Schulze F; Rupp M; Hose D; Secklinger A; Ignatius A; Wilke HJ; Lips KS; Heiss C
    Am J Pathol; 2017 Aug; 187(8):1686-1699. PubMed ID: 28618255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal-regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice.
    Miura T; Etani Y; Noguchi T; Hirao M; Takami K; Goshima A; Kurihara T; Fukuda Y; Ochiai N; Kanamoto T; Nakata K; Okada S; Ebina K
    Bone; 2024 Apr; 181():117026. PubMed ID: 38325651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
    Honma M; Ikebuchi Y; Kariya Y; Suzuki H
    Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
    Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.
    Solberg LB; Stang E; Brorson SH; Andersson G; Reinholt FP
    Histochem Cell Biol; 2015 Feb; 143(2):195-207. PubMed ID: 25201349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of osteoprotegerin on human bone cell metabolism.
    Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
    Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients.
    Alfaqih MA; Bashir N; Saadeh R; Khader Y; Barqawi M; Alqudah S
    BMC Res Notes; 2018 Jul; 11(1):534. PubMed ID: 30064480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial.
    Hooshmand S; Brisco JR; Arjmandi BH
    Br J Nutr; 2014 Jul; 112(1):55-60. PubMed ID: 24780728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.
    Yan Z; Zhu S; Tian X; Ye Z; Zhai D; Zhu Z; Wei D; Zhu Q; Lu Z; Cao X
    J Bone Miner Metab; 2019 May; 37(3):399-410. PubMed ID: 30032440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J; Wang K; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isomeric flavonoid aglycones derived from Epimedii Folium exerted different intensities in anti-osteoporosis through OPG/RANKL protein targets.
    Jiang J; Xiao S; Xu X; Ma H; Feng C; Jia X
    Int Immunopharmacol; 2018 Sep; 62():277-286. PubMed ID: 30036771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT.
    Liu J; Zhang Z; Guo Q; Dong Y; Zhao Q; Ma X
    Phytomedicine; 2018 Mar; 42():43-50. PubMed ID: 29655696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of metformin combined with total flavonoids of Rhizoma Drynariae on ovariectomy-induced osteoporotic rats.
    Jiang N; Jin H; Yang K; Zhang Z; Xu W; Chen X; Zhang Z; Xu H
    Biomed Pharmacother; 2023 Sep; 165():115181. PubMed ID: 37473680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.